GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (LTS:0R6Y) » Definitions » ROE % Adjusted to Book Value

Thor Medical ASA (LTS:0R6Y) ROE % Adjusted to Book Value : -10.52% (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Thor Medical ASA ROE % Adjusted to Book Value?

Thor Medical ASA's ROE % for the quarter that ended in Jun. 2024 was -9.78%. Thor Medical ASA's PB Ratio for the quarter that ended in Jun. 2024 was 0.93. Thor Medical ASA's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -10.52%.


Thor Medical ASA ROE % Adjusted to Book Value Historical Data

The historical data trend for Thor Medical ASA's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thor Medical ASA ROE % Adjusted to Book Value Chart

Thor Medical ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -21.30 -21.30 -17.30 -143.68 -13.88

Thor Medical ASA Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -139.02 -87.86 -16.11 -0.07 -10.52

Competitive Comparison of Thor Medical ASA's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Thor Medical ASA's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thor Medical ASA's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Thor Medical ASA's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Thor Medical ASA's ROE % Adjusted to Book Value falls into.



Thor Medical ASA ROE % Adjusted to Book Value Calculation

Thor Medical ASA's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-15.82% / 1.14
=-13.88%

Thor Medical ASA's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-9.78% / 0.93
=-10.52%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Thor Medical ASA ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Thor Medical ASA's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Thor Medical ASA Business Description

Industry
Traded in Other Exchanges
Address
Karenslyst Alle 9C, Oslo, NOR, 0278
Thor Medical ASA is a company engaged in producing and supplying of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium (Th-232). The objective of the company is to supply alpha emitters to suppliers and developers of innovative drugs targeting indications of high unmet medical need, including any medical products and equipment, and to run business related thereto or associated therewith.

Thor Medical ASA Headlines

No Headlines